$Multiple-level spinal fractures due to adefovir-induced Fanconi syndrome and hypophosphatemic osteomalacia: A case report$

Multiple-level spinal fractures due to adefovir-induced Fanconi syndrome and hypophosphatemic osteomalacia: A case report

Bibliographic Details
Main Authors:	Haichao He, Yong-Jin Zhang
Format:	Article
Language:	English
Published:	Elsevier 2023-04-01
Series:	Asian Journal of Surgery
Subjects:	Fanconi syndrome Osteomalacia Spinal fractures Hepatitis B Adefovir
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958422014191

Similar Items

Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report
by: Tomohisa Kunii, et al.
Published: (2019-04-01)

Adefovir-induced Fanconi syndrome associated with osteomalacia
by: Samel Park, et al.
Published: (2018-09-01)

Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report
by: Tanaka Motoyuki, et al.
Published: (2012-08-01)

Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report
by: Qian Xiang, et al.
Published: (2020-06-01)

Adefovir dipivoxil-induced development of osteomalacia and Fanconi syndrome during the treatment of hepatitis B virus (HBV)-related cirrhosis
by: Orietta Staltari, et al.
Published: (2014-12-01)

Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
by: Sevilay Batıbay, et al.
Published: (2018-08-01)

Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series
by: Nan Chen, et al.
Published: (2018-05-01)

Management of intraoperative periprosthetic fractures in a patient with osteomalacia induced by chronic use of adefovir dipivoxil: A good treatment outcome with a 5-year follow-up
by: Yingwei Bi, et al.
Published: (2023-12-01)

Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil
by: Zhu S, et al.
Published: (2017-12-01)

Fanconi syndrome due to prolonged use of low-dose adefovir
by: Xiao-Bing Wang, et al.
Published: (2015-01-01)

Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?
by: Qian YY, et al.
Published: (2019-04-01)

Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use
by: Mana Rao, et al.
Published: (2021-05-01)

Bilateral atraumatic neck of femur fractures secondary to tenofovir-induced fanconi syndrome
by: Vikaesh Moorthy, et al.
Published: (2023-01-01)

Adult Hypophosphatemic Osteomalacia
by: H. M. Imalingat, et al.
Published: (2015-06-01)

Incapacitating pain from Tenofovir Induced Hypophosphatemic Osteomalacia in a Hemophilia Patient – A Case Report
by: Emma Woo, et al.
Published: (2020-01-01)

Comparison of entecavir and adefovir for the treatment of chronic hepatitis B
by: Si-Hai Zhao, et al.

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
by: Goh Eun Chung, et al.
Published: (2017-03-01)

A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B
by: Dongwoo Kim, et al.
Published: (2016-12-01)

Adefovir Dipivoxil
by: Francisco Javier Hevia-Urrutia
Published: (2008-11-01)

Vitamin D deficiency presenting like hypophosphatemic osteomalacia
by: Rajneesh Mittal, et al.
Published: (2012-01-01)

Hypophosphatemia Due to Adefovir Treatment
by: Nazlım AKTUĞ DEMİR, et al.
Published: (2012-12-01)

The case of oncogenic hypophosphatemic osteomalacia
by: Anna K. Eremkina, et al.
Published: (2020-09-01)

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
by: Byung-Cheol Song
Published: (2016-12-01)

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
by: Hye Won Lee, et al.
Published: (2016-12-01)

Hypophosphatemic rickets: A case of recurrent pathological fractures
by: Arjun Baidya, et al.
Published: (2012-01-01)

New treatments for rare bone diseases: hypophosphatemic rickets/osteomalacia
by: Julia Vieira Oberger Marques, et al.
Published: (2022-12-01)

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
by: Hyun Young Woo, et al.
Published: (2014-06-01)

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
by: Jeong Han Kim, et al.
Published: (2016-06-01)

Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis: Case report and literature review
by: Aman Gupta, et al.
Published: (2015-01-01)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
by: Jeong Han Kim, et al.
Published: (2013-09-01)

Drug-induced Fanconi syndrome in patients with kidney allograft transplantation
by: Zhouqi Tang, et al.
Published: (2022-08-01)

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
by: EunYoung Ze, et al.
Published: (2014-09-01)

Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption
by: Naoko Hidaka, et al.
Published: (2021-12-01)

Decrease in viral load at weeks 12 and 24 in patients with chronic hepatitis B treated with lamivudine or adefovir predicts virological response at week 48 En pacientes con hepatitis crónica B tratados con lamivudina y adefovir el descenso de la viremia en las semanas 12 y 24 tiene valor predictivo de respuesta virológica
by: E. Llop, et al.
Published: (2009-11-01)

Detection of rtN236T mutation associated with adefovir dipivoxil resistance in Hepatitis B infected patients with YMDD mutations in Tehran
by: Seyed Hamidreza Monavari, et al.
Published: (2013-03-01)

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
by: Jeong Han Kim, et al.
Published: (2014-09-01)

Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
by: S. S. Rodionova, et al.
Published: (2019-12-01)

Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study
by: Zhang Jing, et al.
Published: (2011-09-01)

Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico
by: Lorenzo Pradelli, et al.
Published: (2005-12-01)

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
by: Hu Peng, et al.
Published: (2011-08-01)